NCT00655876
Clinical Trial Information
Trial Number: NCT00655876 (ClinicalTrials.gov)
Disease Type:
- Gastrointestinal Neoplasm - Gastroesophageal Cancer
Trial Title:
A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Who Are Treated Without Surgery
Study ID:
RTOG-0436
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00655876-D2 | This dataset will allow users to reproduce the treatment comparison in trial NCT00655876. |
| NCT00655876-D1 | This dataset will allow users to reproduce the treatment comparison in trial NCT00655876. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®